Refine Your Search
USP Global Public Policy Position: Fostering the Use of Novel Excipients in Drug Products; Published 2024.
Learn More
USP Global Policy Position: Excipients: A Blind Spot in Ensuring Medicine Quality and Supply Chain Resilience; Published 2024
Learn More
Identifying and addressing vulnerabilities in the upstream pharmaceutical supply chain are essential to mitigating and preventing drug shortages and to ensuring patients have access to the critical…
Learn More
The United States Pharmacopeia (USP) has been an independent standards-setting organization serving public health needs since it was founded in 1820. Over the two centuries that followed, USP evolved…
Learn More
USP Global Public Policy Position on advanced manufacturing technologies (AMTs) for medical products. Published in 2024.
Learn More
USP White Paper on addressing Barriers to the Development of Complex Generics.
Learn More
The U.S. Pharmacopeia (USP) recognizes that global coordination, harmonization, and convergence efforts among governments and other stakeholders can facilitate and streamline responses and solutions…
Learn More
Promoting geographic diversification of the manufacturing base for U.S. drug products can help reduce supply chain vulnerabilities. Published December 2023.
Learn More
USP supports comprehensive policies and programs to address AMR, including building capabilities among global stakeholders to reduce the proliferation of poor-quality medicines and advocating and…
Learn More
USP Global Public Policy Position published 2024
Learn More